A study from the National Institute of Health indicates that RNA interference (RNAi) technology shows genes may act as a therapeutic treatment for Parkinson’s disease.
Dr. Richard Youle. Ph.D, of the National Institute of Neurological Disorders and Stroke (NINDS) along with researchers from the National Center for Advancing Translational Sciences (NCATS) found that their findings may help with other diseases that have been caused from damaged mitochondria.
"We discovered a network of genes that may regulate the disposal of dysfunctional mitochondria, opening the door to new drug targets for Parkinson's disease and other disorders," Dr. Youle was quoted as saying.
Stem cell research was used in human nerve cells to conduct this study. This was helpful to researchers for them to point out when mitochondria is damaged.